Clonal Cell Proliferation in Paroxysmal Nocturnal Hemoglobinuria: Evaluation of PIGA Mutations and T-cell Receptor Clonality
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired pluripotent hematopoietic stem cell disorder associated with an increase in the number of glycosyl-phosphatidyl inositol (GPI)-deficient blood cells. We investigated PNH clonal proliferation in the three cell lineages—granulocytes, T lymphocytes, and red blood cells (RBCs)—by analyzing PIGA gene mutations and T-cell receptor (TCR) clonality. Methods: Flow cytometry was used on peripheral blood samples from 24 PNH patients to measure the GPI-anchored protein (GPI-AP) deficient fraction in each blood cell lineage. PIGA gene mutations were analyzed in granulocytes and T lymphocytes by Sanger sequencing. A TCR clonality assay was performed in isolated GPI-AP deficient T lymphocytes. Results: The GPI-AP deficient fraction among the three lineages was the highest in granulocytes, followed by RBCs and T lymphocytes. PIGA mutations were detected in both granulocytes and T lymphocytes of 19 patients (79.2%), with a higher mutation burden in granulocytes. The GPI-AP deficient fractions of granulocytes and T lymphocytes correlated moderately (rs=0.519, P=0.049) and strongly (rs=0.696, P=0.006) with PIGA mutation burden, respectively. PIGA mutations were more frequently observed in patients with clonal rearrangements in TCR genes (P=0.015). The PIGA mutation burden of T lymphocytes was higher in patients with clonal TCRB rearrangement. Conclusions: PIGA mutations were present in approximately 80% of PNH patients. PNH clone size varies according to blood cell lineage, and clonal cells may obtain proliferation potential or gain a survival advantage over normal cells.
Abstract
Background: Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired pluripotent hematopoietic stem cell disorder associated with an increase in the number of glycosyl-phosphatidyl inositol (GPI)-deficient blood cells. We investigated PNH clonal proliferation in the three cell lineages—granulocytes, T lymphocytes, and red blood cells (RBCs)—by analyzing PIGA gene mutations and T-cell receptor (TCR) clonality. Methods: Flow cytometry was used on peripheral blood samples from 24 PNH patients to measure the GPI-anchored protein (GPI-AP) deficient fraction in each blood cell lineage. PIGA gene mutations were analyzed in granulocytes and T lymphocytes by Sanger sequencing. A TCR clonality assay was performed in isolated GPI-AP deficient T lymphocytes. Results: The GPI-AP deficient fraction among the three lineages was the highest in granulocytes, followed by RBCs and T lymphocytes. PIGA mutations were detected in both granulocytes and T lymphocytes of 19 patients (79.2%), with a higher mutation burden in granulocytes. The GPI-AP deficient fractions of granulocytes and T lymphocytes correlated moderately (rs=0.519, P=0.049) and strongly (rs=0.696, P=0.006) with PIGA mutation burden, respectively. PIGA mutations were more frequently observed in patients with clonal rearrangements in TCR genes (P=0.015). The PIGA mutation burden of T lymphocytes was higher in patients with clonal TCRB rearrangement. Conclusions: PIGA mutations were present in approximately 80% of PNH patients. PNH clone size varies according to blood cell lineage, and clonal cells may obtain proliferation potential or gain a survival advantage over normal cells.
참고문헌 (33)
- Bessler M, "Paroxysmal nocturnal haemoglobinuria(PNH)is caused by somatic mutations in the PIG-A gene", EMBO J, 13, pp.110~117 (1994)
- Ware RE, "Mutations within the Piga gene in patients with paroxysmal nocturnal hemoglobinuria", Blood, 83, pp.2418~2422 (1994)
- Brodsky RA, "Resistance of paroxysmal nocturnal hemoglobinuria cells to the glycosylphosphatidylinositol-binding toxin aerolysin", Blood, 93, pp.1749~1756 (1999)
- Fujita M, "GPI-anchor remodeling : potential functions of GPI-anchors in intracellular trafficking and membrane dynamics", Biochim Biophys Acta, 1821, pp.1050~1058 (2012)
- Kinoshita T, "Biosynthesis, remodelling and functions of mammalian GPI-anchored proteins : recent progress", J Biochem, 144, pp.287~294 (2008)
- Brodsky RA, "How I treat paroxysmal nocturnal hemoglobinuria", Blood, 113, pp.6522~6527 (2009)
- Brodsky RA, "How do PIG-A mutant paroxysmal nocturnal hemoglobinuria stem cells achieve clonal dominance", Expert Rev Hematol, 2, pp.353~356 (2009)
- Hill A, "Paroxysmal nocturnal haemoglobinuria", Nat Rev Dis Primers, 3, pp.17028~ (2017)
- Parker C, "Diagnosis and management of paroxysmal nocturnal hemoglobinuria", Blood, 106, pp.3699~3709 (2005)
- Kim JS, "Distinct subgroups of paroxysmal nocturnal hemoglobinuria(PNH)with cytopenia : results from South Korean National PNH Registry", Ann Hematol, 95, pp.125~133 (2016)
- Donohue RE, "Standardized high-sensitivity flow cytometry testing for paroxysmal nocturnal hemoglobinuria in children with acquired bone marrow failure disorders : A single center US study", Cytometry B Clin Cytom, 94, pp.699~704 (2018)
- Rahman K, "Fluorescent aerolysin(FLAER)-based paroxysmal nocturnal hemoglobinuria(PNH)screening : a single center experience from India", Int J Lab Hematol, 39, pp.261~271 (2017)
- Battiwalla M, "Multiparameter flow cytometry for the diagnosis and monitoring of small GPI-deficient cellular populations", Cytometry B Clin Cytom, 78, pp.348~356 (2010)
- Oh H, "Neutrophil isolation protocol", J Vis Exp, 17 (2008)
- Mortazavi Y, "The spectrum of PIG-A gene mutations in aplastic anemia", paroxysmal nocturnal hemoglobinuria(AA, Blood, pp.2003, 101[DOI]
- Adzhubei IA, "A method and server for predicting damaging missense mutations", Nat Methods, 7, pp.248~249 (2010)
- Choi Y, "Predicting the functional effect of amino acid substitutions and indels", PLoS One, 7, pp.e46688~ (2012)
- Roy S, "Detecting and quantifying low level gene variants in sanger sequencing traces using the ab1 peak reporter tool", J Biomol Tech, 25, pp.S13~S14 (2014)[DOI]
- 최철원, "Efficacy of eculizumab in paroxysmal nocturnal hemoglobinuria patients with or without aplastic anemia: prospective study of a Korean PNH cohort", Blood Research, 52(3), pp.207~211 (2017), 대한혈액학회
- Nafa K, "Mutations in the PIG-A gene causing paroxysmal nocturnal hemoglobinuria are mainly of the frameshift type", Blood, 86, pp.4650~4655 (1995)
- Brodsky RA, "Paroxysmal nocturnal hemoglobinuria", Blood, 124, pp.2804~2811 (2014)
- Ratajczak J, "A novel view of paroxysmal nocturnal hemoglobinuria pathogenesis : more motile PNH hematopoietic stem", progenitor cells displace normal HSPC’s from their niches in bone marrow due to defective adhesion, enhanced migration and mobilization in response to erythrocyte-released sphingosine-1 phosphate gradient, 2012, pp.26, 1722~1725
- Kinoshita T, "Biosynthesis and deficiencies of glycosylphosphatidylinositol", Proc Jpn Acad Ser B Phys Biol Sci, 90, pp.130~143 (2014)
- Krawitz PM, "A case of paroxysmal nocturnal hemoglobinuria caused by a germline mutation and a somatic mutation in PIGT", Blood, 122, pp.1312~1315 (2013)
- Nafa K, "The spectrum of somatic mutations in the PIG-A gene in paroxysmal nocturnal hemoglobinuria includes large deletions and small duplications", Blood Cells Mol Dis, 24, pp.370~384 (1998)
- Yoon JH, "Mutation analysis of the PIG-A gene in Korean patients with paroxysmal nocturnal haemoglobinuria", J Clin Pathol, 55, pp.410~413 (2002)
- Wang H, "Relative increase of granulocytes with a paroxysmal nocturnal haemoglobinuria phenotype in aplastic anaemia patients : the high prevalence at diagnosis", Eur J Haematol, 66, pp.200~205 (2001)
- Mukhina GL, "Multilineage glycosylphosphatidylinositol anchor-deficient haematopoiesis in untreated aplastic anaemia", Br J Haematol, 115, pp.476~482 (2001)
- Pu JJ, "The small population of PIG-A mutant cells in myelodysplastic syndromes do not arise from multipotent hematopoietic stem cells", Haematologica, 97, pp.1225~1233 (2012)
- Wiedmer T, "Complement-induced vesiculation and exposure of membrane prothrombinase sites in platelets of paroxysmal nocturnal hemoglobinuria", Blood, 82, pp.1192~1196 (1993)
- Christmas SE, "Levels of expression of complement regulatory proteins CD46, CD55 and CD59 on resting and activated human peripheral blood leucocytes", Immunology, 119, pp.522~528 (2006)
- Michie CA, "Lifespan of human lymphocyte subsets defined by CD45 isoforms", Nature, 360, pp.264~265 (1992)
- Tseng JE, "Phenotypic and functional analysis of lymphocytes in paroxysmal nocturnal hemoglobinuria", Am J Hematol, 50, pp.244~253 (1995)